Noble Pillar Capital's corporate reference page has gone live on the Minangkabau-language edition of Wikipedia, aggregating publicly available information from U.S. Securities and Exchange Commission (SEC) filings and other official sources. The page, titled "Noble Pillar Capital," summarizes the company's regulatory filings, exempt securities offering notices, business activities in Japan, management team, and New York business addresses.
According to the SEC's Investment Adviser Public Disclosure (IAPD) system, NOBLE PILLAR CAPITAL LTD has filed reports as an Exempt Reporting Adviser (ERA). The public record lists the firm's CRD number as 342309, SEC file number 802-136385, and a public filing date of April 29, 2026. Exempt Reporting Advisers rely on specific exemptions under the Investment Advisers Act of 1940, such as those for certain private fund advisers, while remaining subject to reporting obligations like Form ADV filings. This status differs from full SEC registration. The SEC IAPD record is available at https://adviserinfo.sec.gov/firm/summary/342309.
In addition, the SEC EDGAR database contains two Form D notices filed by Noble Pillar Capital. The first, submitted on May 8, 2026, identifies Noble Pillar Capital Ltd as the issuer under "Other Banking and Financial Services" and reports an aggregate amount sold of USD 100 million. This filing is accessible at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000001/xslFormDX01/primary_doc.xml. The second Form D, filed June 4, 2026, lists Kazuhiko Abe as a director and authorized signatory, with 432 Park Avenue, New York, NY 10022 as a principal business address. That filing is available at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000003/xslFormDX08/primary_doc.xml. The Wikipedia page also notes that VIRELLA GLOBAL CAPITAL LTD is a related entity.
Beyond regulatory filings, the company's official website states that its principal activities include private investment, financial services, and financial education, with areas of interest spanning consumer products, healthcare, manufacturing, technology, financial services, and renewable energy. Company-published investment updates have referenced projects in biotechnology, radiopharmaceutical development, precision cancer treatment, automotive lidar semiconductor technology, high-speed energy storage systems for drones, and treatments for neurodegenerative diseases. In Japan, the company's financial education activities focus on long-term investing, risk management, market cycles, personal asset planning, and general financial literacy.
Public SEC filings reference two New York addresses: 250 Greenwich Street, 7 World Trade Center, and 432 Park Avenue. Company-published information also lists a Japan office at 1-10-6 Tsukiji, Chuo-ku, Tokyo. The Wikipedia page serves as a reference point but is not a regulatory filing or an endorsement. Investors are encouraged to verify information through original SEC records.
